Tema Etfs LLC Makes New $1.56 Million Investment in CVS Health Corporation $CVS

Tema Etfs LLC bought a new stake in CVS Health Corporation (NYSE:CVS) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 20,683 shares of the pharmacy operator’s stock, valued at approximately $1,559,000.

A number of other large investors have also bought and sold shares of the business. SOA Wealth Advisors LLC. boosted its stake in CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 131 shares in the last quarter. Symmetry Partners LLC raised its holdings in shares of CVS Health by 2.5% in the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after buying an additional 141 shares during the last quarter. Harbor Capital Advisors Inc. grew its holdings in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares during the last quarter. HF Advisory Group LLC grew its holdings in CVS Health by 2.9% during the 3rd quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock worth $393,000 after acquiring an additional 145 shares during the last quarter. Finally, United Asset Strategies Inc. increased its position in CVS Health by 1.8% in the 3rd quarter. United Asset Strategies Inc. now owns 8,852 shares of the pharmacy operator’s stock valued at $667,000 after acquiring an additional 154 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

Shares of CVS opened at $80.36 on Tuesday. The firm’s 50 day moving average price is $78.73 and its two-hundred day moving average price is $74.02. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a twelve month low of $49.52 and a twelve month high of $85.15. The firm has a market cap of $102.02 billion, a P/E ratio of 211.49, a PEG ratio of 0.74 and a beta of 0.48.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Analyst Upgrades and Downgrades

CVS has been the subject of several research analyst reports. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Morgan Stanley boosted their target price on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Wolfe Research raised their price target on CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, December 8th. UBS Group reissued an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Finally, Jefferies Financial Group lifted their price target on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $94.86.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.